Revenue
2023
2024
2025
Atrium Therapeutics, Inc. (RNA)
Price$14.03Cached quote
Financial statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | $18.6M | $10.9M | $9.8M |
| Research & development | $53.8M | $19.2M | $12.7M |
| Operating expenses | $95.4M | $24.1M | $16.1M |
| Operating income | −$76.8M | −$13.2M | −$6.4M |
| Operating margin | −412.58% | −121.30% | −65.40% |
| EBITDA | −$76.5M | −$13.0M | −$6.2M |
| EBITDA margin | −410.84% | −119.72% | −63.99% |
| Net income | −$76.7M | −$25.1M | −$6.4M |
| Net profit margin | −411.88% | −230.54% | −65.39% |
| Basic EPSper basic share | -$2.89 | -$1.47 | -$0.37 |
| Diluted EPSper diluted share | -$2.89 | -$1.47 | -$0.37 |
Owners
Reported shareholders
8.77%of listed shares
Sessa Capital IM, L.P.1.5M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
Sessa Capital IM, L.P. | 8.77%1.5M shares |
PRICE T ROWE ASSOCIATES INC /MD/ | 8.61%1.47M shares |
BlackRock, Inc. | 8.46%1.45M shares |
CRCM LP | 7.50%1.28M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 4.27%730.83K shares |
TIG Advisors, LLC | 3.28%561.53K shares |
Arbiter Partners Capital Management LLC | 3.05%522.58K shares |
CANTOR FITZGERALD, L. P. | 3.00%513.83K shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.26%386.93K shares |
TWO SIGMA INVESTMENTS, LP | 2.02%345.48K shares |
GOLDMAN SACHS GROUP INC | 1.81%310.34K shares |
683 Capital Management, LLC | 1.75%300K shares |
STATE STREET CORP | 1.59%271.76K shares |
Boyce Sarah | ≈1.55%265.09K shares |
Slotnik Capital, LLC | 1.39%237.64K shares |
Weiss Asset Management LP | 1.28%219.73K shares |
MILLENNIUM MANAGEMENT LLC | 1.17%200.56K shares |
Schonfeld Strategic Advisors LLC | 1.16%199.16K shares |
AQR CAPITAL MANAGEMENT LLC | 1.01%172.24K shares |
NEXPOINT ASSET MANAGEMENT, L.P. | 0.88%150.03K shares |
Percentages use 17.11M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data